Discriminative stimulus effects of the GABAB receptor-positive modulator rac-BHFF: Comparison with GABAB receptor agonists and drugs of abuse

Journal of Pharmacology and Experimental Therapeutics

Volumn 344, Issue 3, 2013, Pages 553-560

  Koek, Wouter ^a   Cheng, Kejun ^b   Rice, Kenner C ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,6 DI TERT BUTYL 4 (3 HYDROXY 2,2 DIMETHYLPROPYL)PHENOL; 3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; 4 HYDROXYBUTYRIC ACID; 5,7 DI TERT BUTYL 3 HYDROXY 3 TRIFLUOROMETHYL 3H BENZOFURAN 2 ONE; ALCOHOL; BACLOFEN; BENZODIAZEPINE DERIVATIVE; CHOLECYSTOKININ OCTAPEPTIDE; COCAINE; DIAZEPAM; NICOTINE; UNCLASSIFIED DRUG;

ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG ABUSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVITY; LOW DRUG DOSE; MODULATION; NONHUMAN; PIGEON; PRIORITY JOURNAL; PROTEIN FUNCTION; TOBACCO DEPENDENCE;

ANIMALS; BACLOFEN; BENZODIAZEPINES; BENZOFURANS; COCAINE; COLUMBIDAE; DIAZEPAM; DISCRIMINATION (PSYCHOLOGY); ETHANOL; GABA-B RECEPTOR AGONISTS; NICOTINE; ORGANOPHOSPHORUS COMPOUNDS; PHENOLS; SODIUM OXYBATE; STREET DRUGS;

EID: 84874417887     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.202226     Document Type: Article

References (54)

1. Adams CL and Lawrence AJ (2007) CGP7930: A positive allosteric modulator of the GABAB receptor. CNS Drug Rev 13:308-316.
2. Addolorato G, Leggio L, Cardone S, Ferrulli A, and Gasbarrini G (2009) Role of the GABA(B) receptor system in alcoholism and stress: Focus on clinical studies and treatment perspectives. Alcohol 43:559-563.
3. Agabio R, Maccioni P, Carai MA, Gessa GL, Froestl W, and Colombo G (2012) The development of medications for alcohol-use disorders targeting the GABAB receptor system. Recent Patents CNS Drug Discov 7:113-128.
4. Bettler B, Kaupmann K, Mosbacher J, and Gassmann M (2004) Molecular structure and physiological functions of GABA(B) receptors. Physiol Rev 84:835-867.
5. Binet V, Brajon C, Le Corre L, Acher F, Pin JP, and Prézeau L (2004) The heptahelical domain of GABA(B2) is activated directly by CGP7930, a positive allosteric modulator of the GABA(B) receptor. J Biol Chem 279:29085-29091.
6. Bowery NG, Bettler B, Froestl W, Gallagher JP, Marshall F, Raiteri M, Bonner TI, and Enna SJ (2002) International Union of Pharmacology. XXXIII. Mammalian g-aminobutyric acid(B) receptors: Structure and function. Pharmacol Rev 54:247-264.
7. Bowery NG (2006) GABAB receptor: A site of therapeutic benefit. Curr Opin Pharmacol 6:37-43.
8. Calver AR, Davies CH, and PangalosM (2002) GABA(B) receptors: From monogamy to promiscuity. Neurosignals 11:299-314.
9. Carai MA, Colombo G, Froestl W, and Gessa GL (2004) In vivo effectiveness of CGP7930, a positive allosteric modulator of the GABAB receptor. Eur J Pharmacol 504:213-216.
10. Carter LP, Chen W, Coop A, Koek W, and France CP (2006) Discriminative stimulus effects of GHB and GABA(B) agonists are differentially attenuated by CGP35348. Eur J Pharmacol 538:85-93.
11. Castelli MP, Casu A, Casti P, Lobina C, Carai MAM, Colombo G, Solinas M, Giunta D, Mugnaini C, and Pasquini S, et al. (2011) Characterization of COR627 and COR628, two novel positive allosteric modulators of the GABAB receptor. J Pharmacol Exp Ther 340:529-538.
12. Chen Y, Menendez-Roche N, and Sher E (2006) Differential modulation by the GABAB receptor allosteric potentiator 2,6-di-tert-butyl-4-(3-hydroxy-2,2- dimethylpropyl)-phenol (CGP7930) of synaptic transmission in the rat hippocampal CA1 area. J Pharmacol Exp Ther 317:1170-1177.
13. Cryan JF, Kelly PH, Chaperon F, Gentsch C, Mombereau C, Lingenhoehl K, Froestl W, Bettler B, Kaupmann K, and Spooren WP (2004) Behavioral characterization of the novel GABAB receptor-positivemodulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. J Pharmacol Exp Ther 310:952-963.
14. Cryan JF and Kaupmann K (2005) Don't worry 'B' happy!: A role for GABA(B) receptors in anxiety and depression. Trends Pharmacol Sci 26:36-43.
15. Filip M, Frankowska M, and Przegalinski E (2007) Effects of GABA(B) receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced selfadministration and drug discrimination. Eur J Pharmacol 574:148-157.
16. Frankowska M, Filip M, and Przegalinski E (2007) Effects of GABAB receptor ligands in animal tests of depression and anxiety. Pharmacol Rep 59:645-655.
17. Gannon RL and Millan MJ (2011) Positive allosteric modulators at GABAB receptors exert intrinsic actions and enhance the influence of baclofen on light-induced phase shifts of hamster circadian activity rhythms. Pharmacol Biochem Behav 99:712-717.
18. Guery S, Floersheim P, Kaupmann K, and Froestl W (2007) Syntheses and optimization of new GS39783 analogues as positive allosteric modulators of GABAB receptors. Bioorg Med Chem Lett 17:6206-6211.
19. Hensler JG, Advani T, Burke TF, Cheng K, Rice KC, and Koek W (2012) GABAB receptor-positive modulators: Brain region-dependent effects. J Pharmacol Exp Ther 340:19-26.
20. Jacobson LH and Cryan JF (2008) Evaluation of the anxiolytic-like profile of the GABAB receptor positive modulator CGP7930 in rodents. Neuropharmacology 54: 854-862.
21. Jensen AA and Spalding TA (2004) Allosteric modulation of G-protein coupled receptors. Eur J Pharm Sci 21:407-420.
22. Kenakin T (2009) A Pharmacology Primer: Theory, Application and Methods, 3rd ed, Elsevier Academic Press, Burlington, MA.
23. Kerr DI and Ong J (1995) GABAB receptors. Pharmacol Ther 67:187-246.
24. Koek W and France CP (2008) Cataleptic effects of gamma-hydroxybutyrate (GHB) and baclofen in mice: Mediation by GABA(B) receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists. Psychopharmacology (Berl) 199:191-198.
25. Koek W, Flores LR, Carter LP, Lamb RJ, Chen W, Wu H, Coop A, and France CP (2004) Discriminative stimulus effects of gamma-hydroxybutyrate in pigeons: Role of diazepam-sensitive and-insensitive GABA(A) and GABA(B) receptors. J Pharmacol Exp Ther 308:904-911.
26. Koek W, Khanal M, and France CP (2007a) Synergistic interactions between 'club drugs': Gamma-hydroxybutyrate and phencyclidine enhance each other's discriminative stimulus effects. Behav Pharmacol 18:807-810.
27. Koek W, Mercer SL, and Coop A (2007b) Cataleptic effects of gamma-hydroxybutyrate (GHB), its precursor gamma-butyrolactone (GBL), and GABAB receptor agonists in mice: Differential antagonism by the GABAB receptor antagonist CGP35348. Psychopharmacology (Berl) 192:407-414.
28. Koek W, Mercer SL, Coop A, and France CP (2009) Behavioral effects of gammahydroxybutyrate, its precursor gamma-butyrolactone, and GABA(B) receptor agonists: Time course and differential antagonism by the GABA(B) receptor antagonist 3-aminopropyl(diethoxymethyl)phosphinic acid (CGP35348). J Pharmacol Exp Ther 330:876-883.
29. Koek W, France CP, Cheng K, and Rice KC (2010) GABAB receptor-positive modulators: Enhancement of GABAB receptor agonist effects in vivo. J Pharmacol Exp Ther 335:163-171.
30. Koek W, France CP, Cheng K, and Rice KC (2012) Effects of the GABAB receptorpositive modulators CGP7930 and rac-BHFF in baclofen-and g-hydroxybutyratediscriminating pigeons. J Pharmacol Exp Ther 341:369-376.
31. Liang JH, Chen F, Krstew E, Cowen MS, Carroll FY, Crawford D, Beart PM, and Lawrence AJ (2006) The GABA(B) receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats. Neuropharmacology 50:632-639.
32. Maccioni P, Pes D, Orrù A, Froestl W, Gessa GL, Carai MA, and Colombo G (2007) Reducing effect of the positive allosteric modulator of the GABA(B) receptor, GS39,783, on alcohol self-administration in alcohol-preferring rats. Psychopharmacology (Berl) 193:171-178.
33. Maccioni P, Fantini N, Froestl W, Carai MA, Gessa GL, and Colombo G (2008) Specific reduction of alcohol's motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783-comparison with the effect of the GABAB receptor direct agonist, baclofen. Alcohol Clin Exp Res 32:1558-1564.
34. Maccioni P, Carai MA, Kaupmann K, Guery S, Froestl W, Leite-Morris KA, Gessa GL, and Colombo G (2009) Reduction of alcohol's reinforcing and motivational properties by the positive allosteric modulator of the GABA(B) receptor, BHF177, in alcohol-preferring rats. Alcohol Clin Exp Res 33:1749-1756.
35. Maccioni P, Flore P, Carai MA, Mugnaini C, Pasquini S, Corelli F, Gessa GL, and Colombo G (2010a) Reduction by the positive allosteric modulator of the GABA (B) receptor, GS39783, of alcohol self-administration in Sardinian alcoholpreferring rats exposed to the "sipper" procedure. Front Psychiatry 1:20.
36. Maccioni P, Thomas AW, Carai MA, Gessa GL, Malherbe P, and Colombo G (2010b) The positive allosteric modulator of the GABA(B) receptor, rac-BHFF, suppresses alcohol self-administration. Drug Alcohol Depend 109:96-103.
37. Maccioni P, Zaru A, Loi B, Lobina C, Carai MA, Gessa GL, Capra A, Mugnaini C, Pasquini S, and Corelli F, et al. (2012) Comparison of the effect of the GABA(B) receptor agonist, baclofen, and the positive allosteric modulator of the GABA(B) receptor, GS39783, on alcohol self-administration in 3 different lines of alcoholpreferring rats. Alcohol Clin Exp Res 36:1748-1766.
38. Malherbe P, Masciadri R, Norcross RD, Knoflach F, Kratzeisen C, Zenner MT, Kolb Y, Marcuz A, Huwyler J, and Nakagawa T, et al. (2008) Characterization of (R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors. Br J Pharmacol 154:797-811.
39. Markou A, Paterson NE, and Semenova S (2004) Role of gamma-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: Potential pharmacotherapies for smoking cessation. Ann N Y Acad Sci 1025:491-503.
40. Mombereau C, Lhuillier L, Kaupmann K, and Cryan JF (2007) GABAB receptorpositive modulation-induced blockade of the rewarding properties of nicotine is associated with a reduction in nucleus accumbens DeltaFosB accumulation. J Pharmacol Exp Ther 321:172-177.
41. Orrù A, Fujani D, Cassina C, Conti M, Di Clemente A, and Cervo L (2012) Operant, oral alcoholic beer self-administration by C57BL/6J mice: Effect of BHF177, a positive allosteric modulator of GABA(B) receptors. Psychopharmacology (Berl) 222:685-700.
42. Orrù A, Lai P, Lobina C, Maccioni P, Piras P, Scanu L, Froestl W, Gessa GL, Carai MA, and Colombo G (2005) Reducing effect of the positive allosteric modulators of the GABA(B) receptor, CGP7930 and GS39783, on alcohol intake in alcoholpreferring rats. Eur J Pharmacol 525:105-111.
43. Parker DA, Marino V, Ong J, Puspawati NM, and Prager RH (2008) The CGP7930 analogue 2,6-di-tert-butyl-4-(3-hydroxy-2-spiropentylpropyl)-phenol (BSPP) potentiates baclofen action at GABA(B) autoreceptors. Clin Exp Pharmacol Physiol 35:1113-1115.
44. Paterson NE, Vlachou S, Guery S, Kaupmann K, Froestl W, and Markou A (2008) Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats. J Pharmacol Exp Ther 326:306-314.
45. Perdona' E, Costantini VJ, Tessari M, Martinelli P, Carignani C, Valerio E, Mok MH, Zonzini L, Visentini F, and Gianotti M, et al. (2011) In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2- piperidinylethanol (CMPPE). Neuropharmacology 61:957-966.
46. Pilc A and Nowak G (2005) GABAergic hypotheses of anxiety and depression: Focus on GABA-B receptors. Drugs Today (Barc) 41:755-766.
47. Pin J-P, Kniazeff J, Binet V, Liu J, Maurel D, Galvez T, Duthey B, Havlickova M, Blahos J, and Prézeau L, et al. (2004) Activation mechanism of the heterodimeric GABA(B) receptor. Biochem Pharmacol 68:1565-1572.
48. Pinard A, Seddik R, and Bettler B (2010) GABAB receptors: Physiological functions and mechanisms of diversity. Adv Pharmacol 58:231-255.
49. Urwyler S, Mosbacher J, Lingenhoehl K, Heid J, Hofstetter K, Froestl W, Bettler B, and Kaupmann K (2001) Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3- hydroxy-2, 2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol Pharmacol 60:963-971.
50. Urwyler S, Pozza MF, Lingenhoehl K, Mosbacher J, Lampert C, Froestl W, Koller M, and Kaupmann K (2003) N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro- pyrimidine-4,6-diamine (GS39783) and structurally related compounds: Novel allosteric enhancers of gamma-aminobutyric acidB receptor function. J Pharmacol Exp Ther 307:322-330.
51. Urwyler S, Gjoni T, Koljatic J, and Dupuis DS (2005) Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: Effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties. Neuropharmacology 48:343-353.
52. Vlachou S, Guery S, Froestl W, Banerjee D, Benedict J, Finn MG, and Markou A (2011) Repeated administration of the GABAB receptor positive modulator BHF177 decreased nicotine self-administration, and acute administration decreased cueinduced reinstatement of nicotine seeking in rats. Psychopharmacology (Berl) 215: 117-128.
53. Vlachou S and Markou A (2010) GABAB receptors in reward processes. Adv Pharmacol 58:315-371.
54. Wieronska JM, Kusek M, Tokarski K, Wabno J, Froestl W, and Pilc A (2011) The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice. Br J Pharmacol 163:1034-1047.